Jonathan Gerber, MD of Levine Cancer Institute, talks about how targeting leukemia stem cell population may cure AML overall at the 58th ASH Annual Meeting in San Diego, CA.
Targeting Leukemia Stem Cell Populations and Eradicating Them May Lead to Cure in AML
